Clinical Study
Delphinol® maqui berry extract for blood sugar management
Delphinol® displays marked antioxidant powers in ORAC testing (> 30000 µM TE/g), with significantly lowered oxidised LDL by 40% and F2-isoprostane by 28%, in placebo controlled clinical trial. Delphinol® inhibits intestinal glucose transporter SGLT (patented) and hence extends to lower blood sugar absorption to include consumed refined sugars such as glucose. Clinical trials point to high efficacy and excellent tolerability.
